These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9115957)

  • 1. Angiotensin-converting enzyme inhibitors and coronary artery disease.
    Sayer JW; Timmis AD
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():631-7. PubMed ID: 9115957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ischemic effects of angiotensin-converting enzyme inhibitors: a future therapeutic perspective.
    Ambrosioni E; Bacchelli S; Esposti DD; Borghi C
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S3-9. PubMed ID: 11392476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Ferrari R; Ceconi C; Curello S; Pepi P; Mazzoletti A; Visioli O
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():639-47. PubMed ID: 9115958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease.
    Riegger GA
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():613-5. PubMed ID: 9115954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ischemic potential of drugs related to the renin-angiotensin system.
    Ertl G; Hu K
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S11-20. PubMed ID: 11392474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
    Pepine CJ
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-58-64. PubMed ID: 9422854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ACE inhibition on myocardial ischaemia.
    Ferrari R
    Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?
    Remme WJ
    Drugs; 1997; 54 Suppl 5():59-70. PubMed ID: 9429846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
    Young JB
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition and coronary artery disease.
    Pepine CJ
    J Hypertens Suppl; 1994 Jul; 12(4):S65-71. PubMed ID: 7965277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B
    Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of protective effects of ACE inhibition on coronary artery disease.
    Dzau VJ
    Eur Heart J; 1998 Sep; 19 Suppl J():J2-6. PubMed ID: 9796834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition.
    Prasad A; Narayanan S; Husain S; Padder F; Waclawiw M; Epstein N; Quyyumi AA
    Circulation; 2000 Jul; 102(1):35-41. PubMed ID: 10880412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.